| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Anakinra 100mg/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anakinra (substance) |
Inferred relationship |
Some |
|
| Product containing anakinra (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Anakinra (substance) |
Inferred relationship |
Some |
1 |
| Anakinra 100mg/0.67mL injection prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anakinra (substance) |
Inferred relationship |
Some |
|
| anakinra 100 mg/0,67 ml injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anakinra (substance) |
Inferred relationship |
Some |
|
| Anakinra only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Anakinra (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely anakinra 149 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anakinra (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely anakinra 149 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anakinra (substance) |
Inferred relationship |
Some |
1 |
| Product containing only anakinra in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Anakinra (substance) |
Inferred relationship |
Some |
1 |
| Product containing anakinra in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Anakinra (substance) |
Inferred relationship |
Some |
1 |
FHIR